The Regis Duffy BioScience Fund (Duffy BioScience) commenced operations in Prince Edward Island in 2009. The fund was created to invest in emerging bioscience related businesses that are at the commercialization or near commercialization stage of their development with activities in Prince Edward Island.
BioVectra Inc., a company engaged in the manufacture of active pharmaceutical ingredients and commercialization of science based products, provided the initial seed money; the fund's initial capital investment was $1 Million.
Our aim is to increase each project's chances of successfully getting to market and to help small Prince Edward Island bioscience start-up companies carry out their innovation efforts within Prince Edward Island.
Duffy BioScience is accepting Statements of Interest. The Statement of Interest (SOI) is an initial application used for preliminary screening and is subject to our review process.
Applicants will be evaluated on the basis of fit within the Regis Duffy BioScience Fund's mandate, selection criteria and the quality of technology, marketing and business capabilities.